APA (7th ed.) Citation

RW, L., GM, S., AL, W., R, R., A, S., E, H., . . . EJ, S. (2026). Elexacaftor-Tezacaftor-Ivacaftor for Individuals with Residual CFTR Activity: An Open-Label, Nonrandomized Clinical Trial. Annals of the American Thoracic Society. https://doi.org/10.1093/annalsats/aaoag136

Chicago Style (17th ed.) Citation

RW, Linnemann, et al. "Elexacaftor-Tezacaftor-Ivacaftor for Individuals with Residual CFTR Activity: An Open-Label, Nonrandomized Clinical Trial." Annals of the American Thoracic Society 2026. https://doi.org/10.1093/annalsats/aaoag136.

MLA (9th ed.) Citation

RW, Linnemann, et al. "Elexacaftor-Tezacaftor-Ivacaftor for Individuals with Residual CFTR Activity: An Open-Label, Nonrandomized Clinical Trial." Annals of the American Thoracic Society, 2026, https://doi.org/10.1093/annalsats/aaoag136.